Friend Turns Foe: Transformation of Anti-Inflammatory HDL to Proinflammatory HDL during Acute-Phase Response
Author(s) -
Hima Bindu G,
Veena Rao,
Vijay V. Kakkar
Publication year - 2010
Publication title -
cholesterol
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.876
H-Index - 20
eISSN - 2090-1291
pISSN - 2090-1283
DOI - 10.1155/2011/274629
Subject(s) - proinflammatory cytokine , medicine , reverse cholesterol transport , cholesterol , inflammation , high density lipoprotein , pathological , antioxidant , lipoprotein , inflammatory response , bioinformatics , immunology , biochemistry , biology
High-density lipoprotein (HDL) is a major carrier of cholesterol in the blood. Unlike other lipoproteins, physiological functions of HDL influence the cardiovascular system in favorable ways except when HDL is modified pathologically. The cardioprotective mechanism of HDL is mainly based on reverse cholesterol transport, but there has been an emerging interest in the anti-inflammatory and antioxidant roles of HDL. These latter activities of HDL are compromised in many pathological states associated with inflammation. Further, abnormal HDL can become proinflammatory contributing to oxidative damage. In this paper, we discuss the functional heterogeneity of HDL, how alterations in these particles in inflammatory states result in loss of both antioxidant activity and reverse cholesterol transport in relation to atherosclerosis, and the need for assays to predict its functionality.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom